{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:28:19Z","timestamp":1775341699073,"version":"3.50.1"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090757","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T21:52:14Z","timestamp":1394142734000},"page":"e90757","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Lipid Profiles Alter from Pro-Atherogenic into Less Atherogenic and Proinflammatory in Juvenile Idiopathic Arthritis Patients Responding to Anti TNF-\u03b1 Treatment"],"prefix":"10.1371","volume":"9","author":[{"given":"Kuo-Wei","family":"Yeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ming","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Jr","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrrheum.2009.29","article-title":"Management of cardiovascular disease risk in chronic inflammatory disorders","volume":"5","author":"MJ Kaplan","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies","volume":"3","author":"JE Hokanson","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"ref3","first-page":"2089","article-title":"Hyperlipidemia: diagnostic and therapeutic perspectives","volume":"85","author":"CM Ballantyne","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"A Naranjo","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref5","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"RE Petty","year":"1998","journal-title":"J Rheumatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"B Prakken","year":"2011","journal-title":"Lancet"},{"key":"ref7","first-page":"1","article-title":"New Advances in Juvenile Idiopathic Arthritis","volume":"35","author":"JL Huang","year":"2012","journal-title":"Chang Gung Med J"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0950-3579(98)80016-2","article-title":"Cytokines in juvenile chronic arthritis","volume":"12","author":"P Woo","year":"1998","journal-title":"Baillieres Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"T Beukelman","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"I65","DOI":"10.1136\/ard.58.2008.i65","article-title":"Etanercept: therapeutic use in patients with rheumatoid arthritis","volume":"58","author":"L Garrison","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/art.1780351009","article-title":"Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha","volume":"35","author":"BW Deleuran","year":"1992","journal-title":"Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2011.1671","article-title":"Factors associated with treatment response to etanercept in juvenile idiopathic arthritis","volume":"306","author":"MH Otten","year":"2011","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/ard.2007.087593","article-title":"Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry","volume":"68","author":"G Horneff","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/ard.2006.066191","article-title":"Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis","volume":"66","author":"C Popa","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0022-3476(89)80148-9","article-title":"Dyslipoproteinemia in juvenile rheumatoid arthritis","volume":"114","author":"NT Ilowite","year":"1989","journal-title":"J Pediatr"},{"key":"ref16","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"RE Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"ref17","first-page":"2290","article-title":"Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis","volume":"31","author":"CA Wallace","year":"2004","journal-title":"J Rheumatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"ref19","first-page":"757","article-title":"Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention","volume":"5","author":"J Mill\u00e1n","year":"2009","journal-title":"Vasc Health Risk Manag"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/1479164112440713","article-title":"Atherogenic indices and prehypertension in obese and non-obese children","volume":"10","author":"M Rodr\u00edguez-Mor\u00e1n","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1136\/ard.2009.127597","article-title":"Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study","volume":"69","author":"A Jamnitski","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1590\/S1807-59322011000900007","article-title":"Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis","volume":"66","author":"RG Marangoni","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02230355","article-title":"Plasma lipids and lipoproteins in juvenile chronic arthritis","volume":"15","author":"A Bakkaloglu","year":"1996","journal-title":"Clin Rheumatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1546-0096-5-2","article-title":"Homocysteine and lipid profile in children with Juvenile Idiopathic Arthritis","volume":"5","author":"M Gon\u00e7alves","year":"2007","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/1529-0131(199902)42:2<373::AID-ANR21>3.0.CO;2-3","article-title":"Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity","volume":"42","author":"AD Tselepis","year":"1999","journal-title":"Arthritis Rheum"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/01.CCM.0000171272.50888.AD","article-title":"Serum lipids and disease severity in children with severe meningococcal sepsis","volume":"33","author":"CL Vermont","year":"2005","journal-title":"Crit Care Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.semarthrit.2012.10.002","article-title":"Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: A prospective study","volume":"42","author":"CC Shen","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis","volume":"60","author":"IC van Eijk","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.2004.023119","article-title":"Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis","volume":"64","author":"C Popa","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1023\/B:EJEP.0000036572.00663.f2","article-title":"Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis","volume":"19","author":"JW Twisk","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364(9438)","author":"S Yusuf","year":"2004","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090757","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T02:32:44Z","timestamp":1597545164000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090757"}},"subtitle":[],"editor":[{"given":"Cordula M.","family":"Stover","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090757","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}